| A nomogram incorporating PD-L1, NLR, and clinicopathologic features to predict inguinal lymph node metastasis in penile squamous cell carcinoma J Hu, H Li, T He, H Deng, G Gong, Y Cui, P Liu, W Ren, C Li, J Chen, X Zu Urologic Oncology: Seminars and Original Investigations 38 (7), 641. e19-641 …, 2020 | 13 | 2020 |
| PMEPA1 Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder Cancer D Qiu, J Hu, J Hu, A Yu, B Othmane, T He, J Ding, X Cheng, W Ren, X Tan, ... Frontiers in Immunology 12, 705086, 2021 | 12 | 2021 |
| Clinicopathologic features and survival outcomes for primary renal neuroendocrine neoplasms Z Yi, R Liu, J Hu, T He, Z Wang, Y Li, X Zu Clinical Genitourinary Cancer 19 (2), 155-161, 2021 | 12 | 2021 |
| Do cerebral and somatic tissue oxygen saturation measurements correlate with each other during surgery? X Fan, L Lin, G Li, T He, J Xiao, X Deng, F Dai, L Meng Journal of Clinical Monitoring and Computing 34, 483-490, 2020 | 10 | 2020 |
| A preoperative nomogram predicting the pseudocapsule status in localized renal cell carcinoma J Hu, J Chen, H Li, T He, H Deng, G Gong, Y Cui, P Liu, W Ren, X Zhou, ... Translational Andrology and Urology 9 (2), 462, 2020 | 6 | 2020 |
| Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy Y Bao, Y Qiao, JE Choi, Y Zhang, R Mannan, C Cheng, T He, Y Zheng, ... Proceedings of the National Academy of Sciences 120 (49), e2314416120, 2023 | 5 | 2023 |
| Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: a pooled analysis D Qiu, J Hu, T He, H Li, J Hu, Z Yi, J Chen, X Zu Translational Andrology and Urology 9 (5), 2094, 2020 | 5 | 2020 |
| Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies T He, L Xiao, Y Qiao, O Klingbeil, E Young, XS Wu, R Mannan, ... Cancer Cell, 2024 | 4 | 2024 |
| Recurrence factors in patients with Keratinizing squamous metaplasia of the bladder after surgical management: a single-center retrospective study Z Yi, Z Ou, X Guo, B Othmane, J Hu, W Ren, H Li, T He, D Qiu, Z Cai, ... Translational Andrology and Urology 10 (2), 734, 2021 | 4 | 2021 |
| Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer T He, C Cheng, Y Qiao, H Cho, E Young, R Mannan, S Mahapatra, ... Proceedings of the National Academy of Sciences 121 (15), e2322563121, 2024 | 2 | 2024 |
| p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer J Luo, Z Chen, Y Qiao, JCY Tien, E Young, R Mannan, S Mahapatra, T He, ... bioRxiv, 2024.03. 29.587346, 2024 | 2 | 2024 |
| Efficacy of intra-arterial plus intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer: a pooled analysis C Cheng, D Qiu, J Chen, X Zu, J Liu, H Li, J Hu, Z Yi, T He, Z Chen, Y Cui Frontiers in Pharmacology 12, 707271, 2021 | 2 | 2021 |
| Smoking status and pathological response to neoadjuvant chemotherapy among patients with bladder cancer: a pooled analysis T He, J Hu, D Qiu, H Deng, J Hu, J Chen, X Zu Translational andrology and urology 10 (1), 374, 2021 | 2 | 2021 |
| Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader L Liu, A Parolia, Y Liu, C Hou, T He, Y Qiao, S Eyunni, J Luo, C Li, ... Journal of Medicinal Chemistry 67 (9), 6938-6951, 2024 | 1 | 2024 |
| Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer C Cheng, J Hu, R Mannan, R Bhattacharyya, NJ Rossiter, B Magnuson, ... bioRxiv, 2024 | 1 | 2024 |
| PIKfyve controls dendritic cell function and tumor immunity JE Choi, Y Qiao, I Kryczek, J Yu, J Gurkan, Y Bao, M Gondal, JCY Tien, ... bioRxiv, 2024 | 1 | 2024 |
| Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response Y Qiao, JW Wotring, Y Zheng, CJ Zhang, Y Zhang, X Jiang, CD Pretto, ... Proceedings of the National Academy of Sciences 120 (30), e2221809120, 2023 | 1 | 2023 |
| PIKfyve, expressed by CD11c-positive cells, controls tumor immunity JE Choi, Y Qiao, I Kryczek, J Yu, J Gurkan, Y Bao, M Gondal, JCY Tien, ... Nature Communications 15 (1), 5487, 2024 | | 2024 |
| Targeting the SWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies L Xiao, T He, O Klingbeil, Y Eleanor, X Wu, Y Qiao, A Parolia, S Eyunni, ... Cancer Research 84 (6_Supplement), 6602-6602, 2024 | | 2024 |
| Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy P Borker, Y Bao, Y Qiao, A Chinnaiyan, JE Choi, Y Zhang, R Mannan, ... Cancer Research 84 (6_Supplement), 7479-7479, 2024 | | 2024 |
